دورية أكاديمية
PP.02 Tyrosine Kinase Inhibitor (TKI) Real-World Use in Epidermal Growth Factor Receptor Mutated (EGFRm) Advanced Non-small Cell Lung Cancer (NSCLC) Patients.
العنوان: | PP.02 Tyrosine Kinase Inhibitor (TKI) Real-World Use in Epidermal Growth Factor Receptor Mutated (EGFRm) Advanced Non-small Cell Lung Cancer (NSCLC) Patients. |
---|---|
المؤلفون: | Minatta, Jose, Samol, Jens, Moiseenko, Fedor, Demedts, Ingel, Kozlov, Vadim, Mark, Michael, Rajappa, Senthil, Kahangire, Doreen A., Madondo, Mutsa, Bailey, Tom, Wallis, Hannah, Erman, Mustafa, Zukin, Mauro |
المصدر: | Journal of Thoracic Oncology; 2023 Supplement, Vol. 18, pS9-S9, 1p |
قاعدة البيانات: | Complementary Index |